Please log in to determine if you are eligible to purchase PT Programs.
HPV (HIGH RISK) FOR CYTOPATHOLOGY - CHPV
CHPV
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
HPV 5 Three shipments per year
High‑risk HPV genotyping (optional) 5

Additional Information

  • The specimens in this program are not intended to be specific to a transport medium. Laboratories should perform testing using the transport media used in their facility.
  • For laboratories that perform high-risk HPV (HrHPV) genotyping in-house, this program provides opportunities to report specific HPV genotypes, which are educational.
  • The CAP does not report genotyping responses to the CMS.

Program Information

  • Five simulated cervial swab specimens
  • For use in molecular testing

Shipping Schedule

  • Shipment A: February 23
  • Shipment B: July 27
  • Shipment C: December 7






Customers Who Bought This Item Also Bought
HUMAN PAPILLOMAVIRUS
VIEW DETAILS >
IN SITU HYBRIDIZATION
VIEW DETAILS >